Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome.
Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, Morais J, Pordy R, Scemama M, White HD, Schwartz GG; ODYSSEY OUTCOMES Investigators. Steg PG, et al. Can J Cardiol. 2023 Oct;39(10):1315-1324. doi: 10.1016/j.cjca.2023.04.018. Epub 2023 Apr 26. Can J Cardiol. 2023. PMID: 37116789 Free article.
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the national lipid association.
Soffer DE, Marston NA, Maki KC, Jacobson TA, Bittner VA, Peña JM, Thanassoulis G, Martin SS, Kirkpatrick CF, Virani SS, Dixon DL, Ballantyne CM, Remaley AT. Soffer DE, et al. Among authors: bittner va. J Clin Lipidol. 2024 Sep 5:S1933-2874(24)00240-X. doi: 10.1016/j.jacl.2024.08.013. Online ahead of print. J Clin Lipidol. 2024. PMID: 39256087
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.
Zahger D, Schwartz GG, Du W, Szarek M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Jukema JW, Kiss RG, Harrington RA, Moriarty PM, Scemama M, Manvelian G, Pordy R, White HD, Zeiher AM, Fazio S, Geba GP, Steg PG; ODYSSEY OUTCOMES Investigators. Zahger D, et al. Among authors: bittner va. J Am Coll Cardiol. 2024 Sep 10;84(11):994-1006. doi: 10.1016/j.jacc.2024.06.035. J Am Coll Cardiol. 2024. PMID: 39232634 Free article. Clinical Trial.
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models.
Apple SJ, Clark R, Daich J, Gonzalez ML, Ostfeld RJ, Toth PP, Bittner V, Martin SS, Rana JS, Nasir K, Shapiro MD, Virani SS, Slipczuk L. Apple SJ, et al. Among authors: bittner v. Rev Cardiovasc Med. 2023 Dec 13;24(12):350. doi: 10.31083/j.rcm2412350. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077078 Free PMC article. Review.
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study.
Bittner VA, Schwartz GG, Bhatt DL, Chua T, De Silva HA, Diaz R, Goodman SG, Harrington RA, Jukema JW, McGinniss J, Pordy R, Garon G, Scemama M, White HD, Steg PG, Szarek M; ODYSSEY OUTCOMES Investigators. Bittner VA, et al. J Clin Lipidol. 2024 Jul-Aug;18(4):e548-e561. doi: 10.1016/j.jacl.2024.04.122. Epub 2024 Apr 10. J Clin Lipidol. 2024. PMID: 38960812 Free article. Clinical Trial.
Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women's Ischemia Syndrome Evaluation (WISE) study.
Ranasinghe S, Jain A, Taha Y, Handberg E, Johnson BD, Bittner V, Sopko G, Pepine CJ, Anderson RD, Merz CNB. Ranasinghe S, et al. Among authors: bittner v. Am Heart J Plus. 2024 May 31;43:100411. doi: 10.1016/j.ahjo.2024.100411. eCollection 2024 Jul. Am Heart J Plus. 2024. PMID: 38873103 Free PMC article.
409 results